272 related articles for article (PubMed ID: 32785140)
1. Extrahepatic Drug Transporters in Liver Failure: Focus on Kidney and Gastrointestinal Tract.
Droździk M; Oswald S; Droździk A
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785140
[TBL] [Abstract][Full Text] [Related]
2. Impact of kidney dysfunction on hepatic and intestinal drug transporters.
Droździk M; Oswald S; Droździk A
Biomed Pharmacother; 2021 Nov; 143():112125. PubMed ID: 34474348
[TBL] [Abstract][Full Text] [Related]
3. Intestinal drug transporters in pathological states: an overview.
Drozdzik M; Czekawy I; Oswald S; Drozdzik A
Pharmacol Rep; 2020 Oct; 72(5):1173-1194. PubMed ID: 32715435
[TBL] [Abstract][Full Text] [Related]
4. Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication.
Momper JD; Nigam SK
Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):561-570. PubMed ID: 29746174
[TBL] [Abstract][Full Text] [Related]
5. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
[TBL] [Abstract][Full Text] [Related]
6. Abcc6 deficiency in mice leads to altered ABC transporter gene expression in metabolic active tissues.
Ibold B; Faust I; Tiemann J; Gorgels TGMF; Bergen AAB; Knabbe C; Hendig D
Lipids Health Dis; 2019 Jan; 18(1):2. PubMed ID: 30611276
[TBL] [Abstract][Full Text] [Related]
7. Renal and non-renal response of ABC and SLC transporters in chronic kidney disease.
Torres AM; Dnyanmote AV; Granados JC; Nigam SK
Expert Opin Drug Metab Toxicol; 2021 May; 17(5):515-542. PubMed ID: 33749483
[TBL] [Abstract][Full Text] [Related]
8. Systematic Investigation of the Effects of Long-Term Administration of a High-Fat Diet on Drug Transporters in the Mouse Liver, Kidney and Intestine.
Lu X; Dong Y; Jian Z; Li Q; Gong L; Tang L; Zhou X; Liu M
Curr Drug Metab; 2019; 20(9):742-755. PubMed ID: 31475894
[TBL] [Abstract][Full Text] [Related]
9. A Network of SLC and ABC Transporter and DME Genes Involved in Remote Sensing and Signaling in the Gut-Liver-Kidney Axis.
Rosenthal SB; Bush KT; Nigam SK
Sci Rep; 2019 Aug; 9(1):11879. PubMed ID: 31417100
[TBL] [Abstract][Full Text] [Related]
10. Overview: Role of Drug Transporters in Drug Disposition and Its Clinical Significance.
Liu X
Adv Exp Med Biol; 2019; 1141():1-12. PubMed ID: 31571163
[TBL] [Abstract][Full Text] [Related]
11. Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.
Mayati A; Moreau A; Le Vée M; Stieger B; Denizot C; Parmentier Y; Fardel O
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375174
[TBL] [Abstract][Full Text] [Related]
12. Post-translational modifications of transporters.
Czuba LC; Hillgren KM; Swaan PW
Pharmacol Ther; 2018 Dec; 192():88-99. PubMed ID: 29966598
[TBL] [Abstract][Full Text] [Related]
13. The Structure and Mechanism of Drug Transporters.
Roberts AG
Methods Mol Biol; 2021; 2342():193-234. PubMed ID: 34272696
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox.
Özvegy-Laczka C; Ungvári O; Bakos É
Biochem Pharmacol; 2023 Mar; 209():115448. PubMed ID: 36758706
[TBL] [Abstract][Full Text] [Related]
15. The reference liver - ABC and SLC drug transporters in healthy donor and metastatic livers.
Kurzawski M; Szeląg-Pieniek S; Łapczuk-Romańska J; Wrzesiński M; Sieńko J; Oswald S; Droździk M
Pharmacol Rep; 2019 Aug; 71(4):738-745. PubMed ID: 31207436
[TBL] [Abstract][Full Text] [Related]
16. Use of imaging to assess the activity of hepatic transporters.
Hernández Lozano I; Langer O
Expert Opin Drug Metab Toxicol; 2020 Feb; 16(2):149-164. PubMed ID: 31951754
[No Abstract] [Full Text] [Related]
17. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
18. Xenobiotic Transporters in the Kidney: Function and Role in Toxicity.
Shen H; Scialis RJ; Lehman-McKeeman L
Semin Nephrol; 2019 Mar; 39(2):159-175. PubMed ID: 30827339
[TBL] [Abstract][Full Text] [Related]
19. Circadian regulation of transporter expression and implications for drug disposition.
Pácha J; Balounová K; Soták M
Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):425-439. PubMed ID: 33353445
[No Abstract] [Full Text] [Related]
20. Drug Transporter Function--Implications in CKD.
Schwenk MH; Pai AB
Adv Chronic Kidney Dis; 2016 Mar; 23(2):76-81. PubMed ID: 26979146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
